Literature DB >> 29890314

Active components, derived from Kai-xin-san, a herbal formula, increase the expressions of neurotrophic factor NGF and BDNF on mouse astrocyte primary cultures via cAMP-dependent signaling pathway.

Cheng Cao1, Junyuan Xiao2, Mengqiu Liu3, Zishuo Ge4, Renjie Huang5, Mingzhu Qi6, Hongliang Zhu7, Yue Zhu8, Jin-Ao Duan9.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Kai-Xin-San (KXS), an ancient formula composed of Ginseng Radix et Rhizoma, Polygalae Radix, Acori Tatarinowii Rhizoma and Poria, was frequently applied for Alzheimer's disease and major depression disorders for thousands of years. However, its active components and molecular mechanism have not clearly been investigated. AIM OF THE STUDY: We aimed to reveal the active components of KXS on regulating neurotrophic factor NGF and BDNF expressions and its mechanisms on mouse astrocyte primary cultures.
MATERIALS AND METHODS: Extracts of KXS had been prepared by water reflux and chemical standardization was carried out by HPLC-MS/MS. Various ethanol elution components were prepared by eluting ethanol on macro pore resin column and compound identification was carried out by high-resolution mass spectrometry. KXS extract, elution components and identified chemicals were applied on mouse astrocytes and expressions of NGF and BDNF and related metabolic enzymes were analyzed by qPCR and western blotting analysis.
RESULTS: One compatible ratio of KXS named D-652 exerted the best effect on stimulation of NGF and BDNF expressions on mouse astrocytes. 70% ethanol elution fraction of D-652 exerted the highest increase tendency on expressions of NGF and BDNF by activating cAMP-dependent signaling pathway as well as stimulating enzymes accounting for neurotrophic factor synthesis. Combined with compound identification by high-resolution mass spectrometry, ginsenoside Rg1 and Rb1 might be the active compounds of this fraction on increasing NGF and BDNF expressions.
CONCLUSIONS: The active compounds of KXS on increasing NGF and BDNF expressions might be the ginsenosides via activating cAMP-dependent signaling pathway as well as stimulating enzymes accounting for neurotrophic factor synthesis, which partly reveal the target of this formulae supported the clinically usage of this decoction.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Active components; BDNF; Chinese medicine formulae; Kai-xin-san; NGF

Mesh:

Substances:

Year:  2018        PMID: 29890314     DOI: 10.1016/j.jep.2018.06.007

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  15 in total

1.  Yizhi Qingxin Formula Extract Ameliorates Cognitive Decline in Aged Rats via the Brain-Derived Neurotrophic Factor/Tropomyosin Receptor Kinase B Pathway.

Authors:  Lina Ma; Yu Cao; Feixue Wang; Zehui Li; Zhiyong Wang; Yang Yang; Hui Pei; Hao Li
Journal:  Front Pharmacol       Date:  2020-04-30       Impact factor: 5.810

2.  Effects of Tokishakuyakusan on Regeneration of Murine Olfactory Neurons In Vivo and In Vitro.

Authors:  Takuya Noda; Hideaki Shiga; Kentaro Yamada; Masayuki Harita; Yukari Nakamura; Tomoko Ishikura; Masami Kumai; Zenji Kawakami; Atsushi Kaneko; Toshihisa Hatta; Hiromi Sakata-Haga; Hiroki Shimada; Takaki Miwa
Journal:  Chem Senses       Date:  2019-05-29       Impact factor: 3.160

3.  Mahuang-Fuzi-Xixin Decoction Reverses Depression-Like Behavior in LPS-Induced Mice by Regulating NLRP3 Inflammasome and Neurogenesis.

Authors:  Wen Jing; Shanshan Song; Hong Sun; Ying Chen; Quan Zhao; You Zhang; Guoliang Dai; Wenzheng Ju
Journal:  Neural Plast       Date:  2019-11-11       Impact factor: 3.599

Review 4.  Mechanisms of Panax ginseng action as an antidepressant.

Authors:  Yang Jin; Ranji Cui; Lihong Zhao; Jie Fan; Bingjin Li
Journal:  Cell Prolif       Date:  2019-10-10       Impact factor: 6.831

5.  Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease.

Authors:  Yunxia Luo; Dongli Li; Yanfang Liao; Chuipu Cai; Qihui Wu; Hanzhong Ke; Xinning Liu; Huilin Li; Honghai Hong; Yumin Xu; Qi Wang; Jiansong Fang; Shuhuan Fang
Journal:  Front Pharmacol       Date:  2020-04-03       Impact factor: 5.810

6.  Kai-Xin-San Attenuates Doxorubicin-Induced Cognitive Impairment by Reducing Inflammation, Oxidative Stress, and Neural Degeneration in 4T1 Breast Cancer Mice.

Authors:  Wenjiao Lyu; Mingzi Ouyang; Xiaomeng Ma; Tiantian Han; Dajin Pi; Shijun Qiu
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-12       Impact factor: 2.629

Review 7.  Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences.

Authors:  Jing Li; Qingxia Huang; Jinjin Chen; Hongyu Qi; Jiaqi Liu; Zhaoqiang Chen; Daqing Zhao; Zeyu Wang; Xiangyan Li
Journal:  Front Pharmacol       Date:  2021-06-02       Impact factor: 5.810

8.  Study on the Multitarget Synergistic Effects of Kai-Xin-San against Alzheimer's Disease Based on Systems Biology.

Authors:  Sirui Guo; Jiahong Wang; Yunjia Wang; Ying Zhang; Kaishun Bi; Zhou Zhang; Qing Li
Journal:  Oxid Med Cell Longev       Date:  2019-12-31       Impact factor: 6.543

9.  UHPLC-MS/MS method for pharmacokinetic and bioavailability determination of five bioactive components in raw and various processed products of Polygala tenuifolia in rat plasma.

Authors:  Xin Zhao; Baoxin Xu; Peng Wu; Pan Zhao; Changchuan Guo; Yueli Cui; Yanxue Zhang; Xuelan Zhang; Huifen Li
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

10.  Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease.

Authors:  Pengji Yi; Zheyu Zhang; Siqi Huang; Jiahua Huang; Weijun Peng; Jingjing Yang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.